Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Esophageal duplication cyst: case report and review of the literature.

Kolomainen D, Hurley PR, Ebbs SR.

Dis Esophagus. 2017 Nov 1;11(1):62-65. doi: 10.1093/dote/11.1.62. Review. No abstract available.

PMID:
29040485
2.

Metabolic differences between cold stored and machine perfused porcine kidneys: A 1H NMR based study.

Nath J, Smith TB, Patel K, Ebbs SR, Hollis A, Tennant DA, Ludwig C, Ready AR.

Cryobiology. 2017 Feb;74:115-120. doi: 10.1016/j.cryobiol.2016.11.006. Epub 2016 Dec 3.

PMID:
27919740
3.

An examination of inpatient medical record keeping in the Orthopaedic Department of Kilimanjaro Christian Medical Centre (KCMC), Moshi, Tanzania.

Hollis AC, Ebbs SR.

Pan Afr Med J. 2016 Apr 20;23:207. doi: 10.11604/pamj.2016.23.207.8083. eCollection 2016.

4.

Evolution of Renal Transplant Practice Over the Past Decade: A U.K. Center Experience.

Nath J, Field M, Ebbs SR, Smith T, McGrogan D, Al-Shakarchi J, Hodson J, Mellor S, Ready A.

Transplant Proc. 2015 Jul-Aug;47(6):1700-4. doi: 10.1016/j.transproceed.2015.06.001.

PMID:
26293037
5.

The epidemiology and treatment of femur fractures at a northern Tanzanian referral centre.

Hollis AC, Ebbs SR, Mandari FN.

Pan Afr Med J. 2015 Dec 4;22:338. doi: 10.11604/pamj.2015.22.338.8074. eCollection 2015.

6.

The importance of pre-operative axillary ultra-sound and intra-operative sentinel lymph node frozen section analysis in patients with early breast cancer--a 3-year study.

Sanders MM, Waheed S, Joshi S, Pogson C, Ebbs SR.

Ann R Coll Surg Engl. 2011 Mar;93(2):103-5. doi: 10.1308/003588411X12851639108196. Epub 2010 Dec 10.

7.

Pleomorphic adenoma of the breast should be excised with a cuff of normal tissue.

John BJ, Griffiths C, Ebbs SR.

Breast J. 2007 Jul-Aug;13(4):418-20. Review.

PMID:
17593049
8.

Management of breast cysts revisited.

Bhate RD, Chakravorty A, Ebbs SR.

Int J Clin Pract. 2007 Feb;61(2):195-9.

PMID:
17263706
9.

Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.

Dowsett M, Smith IE, Ebbs SR, Dixon JM, Skene A, A'Hern R, Salter J, Detre S, Hills M, Walsh G; IMPACT Trialists Group.

J Natl Cancer Inst. 2007 Jan 17;99(2):167-70.

PMID:
17228000
10.
11.

Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer.

Dowsett M, Smith IE, Ebbs SR, Dixon JM, Skene A, Griffith C, Boeddinghaus I, Salter J, Detre S, Hills M, Ashley S, Francis S, Walsh G, A'Hern R.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 2):1024s-1030s.

12.

Sentinel node biopsy should be supplemented by axillary sampling in patients with small breast cancers.

Adwani A, Ebbs SR, Burton S, Lowe S.

Int Semin Surg Oncol. 2005 Nov 28;2:27.

13.

Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.

Smith IE, Dowsett M, Ebbs SR, Dixon JM, Skene A, Blohmer JU, Ashley SE, Francis S, Boeddinghaus I, Walsh G; IMPACT Trialists Group.

J Clin Oncol. 2005 Aug 1;23(22):5108-16. Epub 2005 Jul 5.

PMID:
15998903
14.

Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2).

Chua S, Smith IE, A'Hern RP, Coombes GA, Hickish TF, Robinson AC, Laing RW, O'Brien ME, Ebbs SR, Hong A, Wardley A, Mughal T, Verrill M, Dubois D, Bliss JM; TOPIC Trial Group.

Ann Oncol. 2005 Sep;16(9):1435-41. Epub 2005 Jun 9.

PMID:
15946977
15.

Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists.

Dowsett M, Ebbs SR, Dixon JM, Skene A, Griffith C, Boeddinghaus I, Salter J, Detre S, Hills M, Ashley S, Francis S, Walsh G, Smith IE.

J Clin Oncol. 2005 Apr 10;23(11):2477-92. Epub 2005 Mar 14.

PMID:
15767642
16.

Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival.

Dowsett M, Smith IE, Ebbs SR, Dixon JM, Skene A, Griffith C, Boeddinghaus I, Salter J, Detre S, Hills M, Ashley S, Francis S, Walsh G; IMPACT Trialists.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):951s-8s.

17.

A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial.

Smith IE, A'Hern RP, Coombes GA, Howell A, Ebbs SR, Hickish TF, O'Brien ME, Mansi JL, Wilson CB, Robinson AC, Murray PA, Price CG, Perren TJ, Laing RW, Bliss JM; TOPIC Trial Group.

Ann Oncol. 2004 May;15(5):751-8.

PMID:
15111342
18.

Seroma following breast cancer surgery.

Pogson CJ, Adwani A, Ebbs SR.

Eur J Surg Oncol. 2003 Nov;29(9):711-7. Review.

PMID:
14602488
19.

Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer.

Archer CD, Parton M, Smith IE, Ellis PA, Salter J, Ashley S, Gui G, Sacks N, Ebbs SR, Allum W, Nasiri N, Dowsett M.

Br J Cancer. 2003 Sep 15;89(6):1035-41.

20.

Multimodality therapy in inflammatory breast cancer: is there a place for surgery?

De Boer RH, Allum WH, Ebbs SR, Gui GP, Johnston SR, Sacks NP, Walsh G, Ashley S, Smith IE.

Ann Oncol. 2000 Sep;11(9):1147-53.

PMID:
11061610
22.

Disappearing microcalcification after neoadjuvant chemotherapy--a case report.

Adwani A, Lowe S, Ebbs SR.

Eur J Surg Oncol. 2000 Feb;26(1):98-100. No abstract available.

PMID:
10718189
23.

Lymphatic relapse in women with early breast cancer: a difficult management problem.

McKinna F, Gothard L, Ashley S, Ebbs SR, Yarnold JR.

Eur J Cancer. 1999 Jul;35(7):1065-9.

PMID:
10533449
24.

The effectiveness of the routine clinic visit in the follow-up of breast cancer patients: analysis of a defined patient cohort.

Loong S, Wilkins M, Bliss JM, Davidson J, Ebbs SR, Regan J, Yarnold JR.

Clin Oncol (R Coll Radiol). 1998;10(2):103-6.

PMID:
9610899
25.

Esophageal duplication cyst: case report and review of the literature.

Kolomainen D, Hurley PR, Ebbs SR.

Dis Esophagus. 1998 Jan;11(1):62-5. No abstract available.

PMID:
9595237
26.

Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer.

Johnston SR, Saccani-Jotti G, Smith IE, Salter J, Newby J, Coppen M, Ebbs SR, Dowsett M.

Cancer Res. 1995 Aug 1;55(15):3331-8.

27.
28.

Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration.

Johnston SR, Haynes BP, Smith IE, Jarman M, Sacks NP, Ebbs SR, Dowsett M.

Lancet. 1993 Dec 18-25;342(8886-8887):1521-2.

PMID:
7902904
29.

Trial of aminoglutethimide vs hydrocortisone as second-line hormone treatment of advanced breast cancer.

Mercer PM, Ebbs SR, Fraser SC, Coltart RS, Bates T.

Eur J Surg Oncol. 1993 Jun;19(3):254-8.

PMID:
8314383
30.
31.

Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.

Fraser SC, Dobbs HJ, Ebbs SR, Fallowfield LJ, Bates T, Baum M.

Br J Cancer. 1993 Feb;67(2):402-6.

32.

A daily diary for quality of life measurement in advanced breast cancer trials.

Fraser SC, Ramirez AJ, Ebbs SR, Fallowfield LJ, Dobbs HJ, Richards MA, Bates T, Baum M.

Br J Cancer. 1993 Feb;67(2):341-6.

33.

Side-effects of screening.

Garstin IW, Kaufman Z, Michell MJ, Rodway A, Ebbs SR, Baum M.

Eur J Cancer. 1993;29A(15):2150-2.

PMID:
8297654
34.

The Purley train crash: procedural difficulties.

Ebbs SR, Fothergill NJ, Hashemi K.

Arch Emerg Med. 1992 Jun;9(2):130-3. No abstract available.

35.

The Purley train crash mechanism: injuries and prevention.

Fothergill NJ, Ebbs SR, Reese A, Partridge RJ, Mowbray M, Southcott RD, Hashemi K.

Arch Emerg Med. 1992 Jun;9(2):125-9.

36.
37.

Assessment of breast cancer size: a comparison of methods.

Pain JA, Ebbs SR, Hern RP, Lowe S, Bradbeer JW.

Eur J Surg Oncol. 1992 Feb;18(1):44-8.

PMID:
1737593
38.

Desmoid tumours treated with triphenylethylenes.

Brooks MD, Ebbs SR, Colletta AA, Baum M.

Eur J Cancer. 1992;28A(6-7):1014-8.

PMID:
1385717
39.

Influence of cholecystectomy on symptoms.

Bates T, Ebbs SR, Harrison M, A'Hern RP.

Br J Surg. 1991 Aug;78(8):964-7.

PMID:
1913118
40.

Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts.

Colletta AA, Wakefield LM, Howell FV, van Roozendaal KE, Danielpour D, Ebbs SR, Sporn MB, Baum M.

Br J Cancer. 1990 Sep;62(3):405-9.

41.
42.

Policeman's groin: an unusual occupational injury.

Ebbs SR.

Injury. 1990 May;21(3):182. No abstract available.

PMID:
2401553
43.

Do all abdominal bullets need to be removed?

Ebbs SR, el-Masry R, Baum M.

Injury. 1990 May;21(3):183-4. No abstract available.

PMID:
2205573
44.

Measurement of quality of life in advanced breast cancer.

Baum M, Ebbs SR, Fallowfield LJ, Fraser SC.

Acta Oncol. 1990;29(3):391-5. Review.

PMID:
2194541
45.

The design of advanced breast cancer trials. New approaches.

Fraser SC, Ebbs SR, Dobbs HJ, Fallowfield LJ, Baum M.

Acta Oncol. 1990;29(3):397-400. Review.

PMID:
1694675
46.

Response of breast carcinoma to endocrine therapy predicted using immunostained pelleted fine needle aspirates.

Heyderman E, Ebbs SR, Larkin SE, Brown BM, Haines AM, Bates T.

Br J Cancer. 1989 Oct;60(4):630-3.

47.

Prospective evaluation of a low maintenance policy for semipermanent silicone vascular access catheters.

Ebbs SR, Saunders JA, Baum M.

Eur J Surg Oncol. 1989 Jun;15(3):220-3.

PMID:
2500368
48.

The role of adjuvant endocrine therapy in primary breast cancer.

Baum M, Ebbs SR.

Recent Results Cancer Res. 1989;115:136-43. No abstract available.

PMID:
2696026
49.

The Cancer Research Campaign trials of adjuvant therapy for early breast cancer.

Baum M, Ebbs SR, Houghton J, A'Hern RP, Riley D.

Acta Oncol. 1989;28(6):907-12.

PMID:
2692654
50.

Advanced breast cancer. A randomised trial of epidoxorubicin at two different dosages and two administration systems.

Ebbs SR, Saunders JA, Graham H, A'Hern RP, Bates T, Baum M.

Acta Oncol. 1989;28(6):887-92.

PMID:
2692652

Supplemental Content

Support Center